New MedixMAB™ KIM-1 antibodies for acute kidney injury
We now expand our kidney marker portfolio with the introduction of four monoclonal KIM-1 antibodies. Kidney injury molecule-1, known as KIM-1, is a promising novel biomarker, mostly used for early detection of acute kidney injury (AKI). The new MedixMAB products are mouse monoclonal antibodies, produced in vitro and raised against the human protein.
- Anti-h KIM-1 10101 SPTN-5, ref. 100738
- Anti-h KIM-1 10102 SPTN-5, ref. 100739
- Anti-h KIM-1 10103 SPTN-5, ref. 100740
- Anti-h KIM-1 10106 SPTN-5, ref. 100742
Samples of the new KIM-1 antibodies are available upon request. Sample ordering and full product specifications are available online.